Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04534218
Title Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer (REPROGRAM-01)
Acronym REPROGRAM-01
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire de Besancon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.